Metacon’s recommendation remains “reduce,” with the target price lowered to SEK 0.12 due to weakened prospects. The company’s growth potential depends on the commercialization of hydrogen technology, but market conditions, financing risks, and a lack of new orders add uncertainty. Additional funding is required to fulfill large-scale orders. The weakened outlook and the sluggish hydrogen sector push the valuation towards the lower end of the price range.
Here is a high-quality and updated analysis of the company. 